Stockreport

FDA Approves EYLEA® (aflibercept) Injection Prefilled Syringe

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF TARRYTOWN, N.Y., Aug. 13, 2019 /PRNewswire/ -- EYLEA is the only anti-VEGF approved to treat four retinal conditions with a single dose strength prefilled syringeEYLEA i [Read more]